{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:33:38Z","timestamp":1792114418447,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012005","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000}}],"reference-count":171,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012005.pub2","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T16:32:31Z","timestamp":1587054751000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Interventions for fatigue in inflammatory bowel disease"],"prefix":"10.1002","volume":"2020","author":[{"given":"Dawn","family":"Farrell","sequence":"first","affiliation":[{"name":"Institute of Technology Tralee; Department of Nursing and Healthcare Sciences; Tralee County Kerry Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micol","family":"Artom","sequence":"additional","affiliation":[{"name":"King's College London; Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care; 57 Waterloo Road London UK SE1 8WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wladyslawa","family":"Czuber-Dochan","sequence":"additional","affiliation":[{"name":"King's College London; Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care; 57 Waterloo Road London UK SE1 8WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars P","family":"Jelsness-J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"\u00d8stfold University College; Health Sciences; H\u00f8gskolen i \u00d8stfold, Postboks 700 Halden Norway NO-1757"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Norton","sequence":"additional","affiliation":[{"name":"King's College London; Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care; 57 Waterloo Road London UK SE1 8WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Savage","sequence":"additional","affiliation":[{"name":"University College Cork; School of Nursing and Midwifery, Brookfield Health Sciences Complex; Cork Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"10.1002\/14651858.CD012005.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13063-017-1926-3","article-title":"Cognitive behavioural therapy for the management of inflammatory bowel disease-fatigue with a nested qualitative element: study protocol for a randomised controlled trial","volume":"18","author":"Artom","year":"2017","journal-title":"Trials"},{"issue":"145","key":"10.1002\/14651858.CD012005.pub2-BIB0002|cit2","article-title":"Cognitive behavioural therapy for the management of inflammatory bowel disease-fatigue: a feasibility randomised controlled trial","volume":"5","author":"Artom","year":"2019","journal-title":"Pilot Feasibility Studies"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0003|cit3","unstructured":"ISRCTN17917944 Management of inflammatory bowel disease-fatigue: a pilot cognitive-behavioural therapy interventional study http:\/\/www.isrctn.com\/ISRCTN17917944"},{"issue":"1","key":"10.1002\/14651858.CD012005.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD012005.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/j.1572-0241.2008.02175.x","article-title":"Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn\u2019s disease: patient-reported outcomes of the CHARM Trial","volume":"103","author":"Loftus","year":"2008","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD012005.pub2-BIB0006|cit6","first-page":"S118","article-title":"Adalimumab maintenance therapy and health related quality of life in TNT-antagonist-na\u00efve patients with Crohn\u2019s disease","volume":"23","author":"Rubin","year":"2009","journal-title":"Journal of the Canadian Association of Gastroenterology"},{"issue":"10114","key":"10.1002\/14651858.CD012005.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial","volume":"390","author":"Colombel","year":"2017","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0008|cit8","unstructured":"NCT01235689 An open-label, multicenter, efficacy and safety study to evaluate two treatment algorithms in subjects with moderate to severe Crohn's Disease clinicaltrials.gov\/ct2\/show\/NCT01235689"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"S078","DOI":"10.1093\/ecco-jcc\/jjx180.108","article-title":"DOP071 Tight control with adalimumab-based treatment is associated with improved quality of life outcomes in patients with moderate to severely active Crohn\u2019s disease: data from CALM","volume":"12","author":"Panaccione","year":"2018","journal-title":"Journal of Crohn's and Colitis"},{"issue":"8","key":"10.1002\/14651858.CD012005.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0011|cit11","unstructured":"NCT00783718 A phase 3, randomized, placebo-controlled, blinded, multicenter study of the induction and maintenance of clinical response and remission by MLN0002 in patients with moderate to severe ulcerative colitis clinicaltrials.gov\/ct2\/show\/NCT00783718"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD012005.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"S394","DOI":"10.1093\/ecco-jcc\/jjx180.697","article-title":"P570 Improvements in subcomponents of the inflammatory bowel disease questionnaire in patients treated with vedolizumab: results from GEMINI trial data","volume":"12","author":"Rubin","year":"2018","journal-title":"Journal of Crohn's and Colitis"},{"issue":"4","key":"10.1002\/14651858.CD012005.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0005-7967(03)00146-3","article-title":"A stress management programme for Crohn\u2019s disease","volume":"42","author":"Garc\u00eda-Vega","year":"2004","journal-title":"Behaviour Research and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD012005.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/MIB.0000000000000314","article-title":"Ferric Maltol is effective in correcting iron deficiency anaemia in patients with inflammatory bowel disease: results from a Phase-3 clinical trial program","volume":"21","author":"Gasche","year":"2015","journal-title":"Inflammatory Bowel Diseases"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD012005.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1097\/01.MIB.0000438821.26871.26","article-title":"Efficacy and safety of intravenous Ferunoxytol for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease","volume":"19","author":"Hetzel","year":"2013","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1016\/S1873-9946(14)60557-2","article-title":"Intravenous (IV) ferumoxytol (FER) for the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease (IBD): efficacy, safety and health-related quality of life (HRQOL)","volume":"8","author":"Hetzel","year":"2014","journal-title":"Journal of Crohn's and Colitis"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD012005.pub2-BIB0017|cit17","first-page":"A293","article-title":"A prospective randomised study: electroacupuncture vs. sham procedure for the treatment of fatigue in patients with quiescent inflammatory bowel disease","volume":"5","author":"Horta","year":"2017","journal-title":"United European Gastroenterology Journal"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1093\/ecco-jcc\/jjw019.650","article-title":"Inflammatory bowel disease and fatigue: the effect of physical activity and\/or omega-3 supplementation","volume":"10","author":"McNelly","year":"2016","journal-title":"Journal of Crohn's and Colitis"},{"issue":"8","key":"10.1002\/14651858.CD012005.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.12968\/gasn.2016.14.8.39","article-title":"The effect of increasing physical activity and\/or omega-3 supplementation on fatigue in inflammatory bowel disease","volume":"14","author":"McNelly","year":"2016","journal-title":"Gastrointestinal Nursing"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0020|cit20","unstructured":"NCT01792388 Vitamin D and its effects on inflammation and intestinal permeability in Crohn's disease in remission clinicaltrials.gov\/ct2\/show\/NCT01792388"},{"issue":"5","key":"10.1002\/14651858.CD012005.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1016\/S0016-5085(13)60804-5","article-title":"Vitamin D supplementation improves muscles strength, fatigue and quality of life in patients with Crohn\u2019s disease in remission: results of a randomised double-blind placebo-controlled study","volume":"144","author":"Raftery","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0022|cit22","unstructured":"NCT00783692 A phase 3, randomized, placebo-controlled, blinded, multicenter study of the induction and maintenance of clinical response and remission by vedolizumab (MLN0002) in patients with moderate to severe Crohn's Disease clinicaltrials.gov\/ct2\/show\/study\/NCT00783692"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD012005.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"S394","DOI":"10.1093\/ecco-jcc\/jjx180.697","article-title":"P570 Improvements in subcomponents of the inflammatory bowel disease questionnaire in patients treated with vedolizumab: results from GEMINI trial data","volume":"12","author":"Rubin","year":"2018","journal-title":"Journal of Crohn's and Colitis"},{"issue":"8","key":"10.1002\/14651858.CD012005.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn's disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012005.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"e0150191","DOI":"10.1371\/journal.pone.0150191","article-title":"Effect of a medicinal agaricus blazei murill-based mushroom extract, AndoSan\u2122, on symptoms, fatigue and quality of life in patients with ulcerative colitis in a randomized single-blinded placebo controlled study","volume":"11","author":"Therkelsen","year":"2016","journal-title":"PlOS One"},{"issue":"7","key":"10.1002\/14651858.CD012005.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"e0159288","DOI":"10.1371\/journal.pone.0159288","article-title":"Effect of the medicinal agaricus blazei murill-based mushroom extract, AndoSanTM, on symptoms, fatigue and quality of life in patients with Crohn\u2019s Disease in a randomized single-blinded placebo controlled study","volume":"11","author":"Therkelsen","year":"2016","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0028|cit27","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/S1873-9946(13)60524-3","article-title":"Fatigue in IBD patients decreases with psychotherapy: results of a randomized controlled trial","volume":"7","author":"Vogelaar","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0027|cit28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/gutjnl-2013-305191","article-title":"Fatigue management in patients with IBD: a randomised controlled trial","volume":"63","author":"Vogelaar","year":"2014","journal-title":"Gut"},{"issue":"9","key":"10.1002\/14651858.CD012005.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/ibd.21575","article-title":"INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease specific quality of life in distressed patients with ulcerative colitis or Crohn's disease? A randomised controlled trial","volume":"17","author":"Boye","year":"2011","journal-title":"Inflammatory Bowel diseases"},{"issue":"15","key":"10.1002\/14651858.CD012005.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012005.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1053\/j.gastro.2013.04.048","article-title":"Early administration of azathioprine vs conventional management of Crohn's disease: a randomised controlled trial","volume":"145","author":"Cosnes","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD012005.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/gutjnl-2013-304488","article-title":"Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)","volume":"63","author":"Dewint","year":"2014","journal-title":"Gut"},{"issue":"10","key":"10.1002\/14651858.CD012005.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/j.1572-0241.2003.07674.x","article-title":"The effects of infliximab maintenance therapy on health-related quality of life","volume":"98","author":"Feagan","year":"2003","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/CEG.S101473","article-title":"Ferumoxytol versus placebo in iron deficiency anaemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders","volume":"9","author":"Ford","year":"2016","journal-title":"Clinical and Experimental Gastroenterology"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1016\/S1873-9946(13)60506-1","article-title":"IV iron treatment of iron deficiency anaemia with ferumoxytol in patients with gastrointestinal disorders unable to take oral iron: a randomised controlled trial versus iron sucrose","volume":"7","author":"Hetzel","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"issue":"6","key":"10.1002\/14651858.CD012005.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/gut.49.6.790","article-title":"A randomised controlled trail of high versus low long chain triglyceride whole protein feed in active Crohn's disease","volume":"49","author":"Leiper","year":"2001","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD012005.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00054725-200207000-00001","article-title":"Infliximab improves quality of life in patients with Crohn\u2019s disease","volume":"8","author":"Lichtenstein","year":"2002","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012005.pub2-BIB0038|cit38","article-title":"Adalimumab treatment associated with rapid and significant improvement in health-related quality of life in patients with Crohn\u2019s disease","volume":"23","author":"Loftus","year":"2009","journal-title":"Journal of the Canadian Association of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012005.pub2-BIB0039|cit39","first-page":"400","article-title":"Long-term efficacy of vedolizumab for ulcerative colitis","volume":"11","author":"Loftus","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0040|cit40","first-page":"363","article-title":"Feasibility and effectiveness of a psycho-educational program in adolescents with Inflammatory Bowel Disease (IBD)","volume":"61","author":"Maragkoudaki","year":"2016","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD012005.pub2-BIB0041|cit41","first-page":"509","article-title":"Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn\u2019s disease: a pilot randomized placebo-controlled trial","volume":"11","author":"Mikocka-Walus","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"issue":"14","key":"10.1002\/14651858.CD012005.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.3748\/wjg.v13.i14.2089","article-title":"Crohn\u2019s disease, fatigue, and infliximab: Is there a role for cytokines in the pathogenesis of fatigue?","volume":"13","author":"Minderhoud","year":"2007","journal-title":"World of Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0043|cit43","unstructured":"NCT01991314 Treatment of iron deficiency anaemia in adults and adolescents with inflammatory bowel disease using ferrous sulphate: tolerance and effects on haemoglobin, mood, quality of life and fatigue clinicaltrials.gov\/ct2\/show\/NCT01991314"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0044|cit44","unstructured":"NCT02148718 Rapidity of onset of response to adalimumab in luminal Crohn's disease (RAPIDA Study) clinicaltrials.gov\/ct2\/show\/NCT02148718"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0045|cit45","unstructured":"NCT02162862 Treating disrupted sleep in individuals with inflammatory bowel disease: a novel adjunctive therapy for chronic inflammatory illness clinicaltrials.gov\/ct2\/show\/NCT02162862"},{"issue":"10075","key":"10.1002\/14651858.CD012005.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-230X-9-22","article-title":"Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study","volume":"9","author":"Pena Rossi","year":"2009","journal-title":"BMC Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012005.pub2-BIB0048|cit48","first-page":"A476","article-title":"The evolution of fatigue in patients with Crohn's disease after treatment with infliximab: a prospective study","volume":"126","author":"Persoons","year":"2004","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD012005.pub2-BIB0049|cit49","first-page":"782","article-title":"Self-management education for rehabilitation inpatients suffering from inflammatory bowel disease: a cluster randomized controlled trial","volume":"31","author":"Reusch","year":"2016","journal-title":"Health Education Research"},{"issue":"2","key":"10.1002\/14651858.CD012005.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.gastro.2008.04.023","article-title":"A randomised, double-blind, sham-controlled study of granulocyte\/monocyte apheresis for active ulcerative colitis","volume":"135","author":"Sands","year":"2008","journal-title":"Gastreoenterology"},{"issue":"9","key":"10.1002\/14651858.CD012005.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/gutjnl-2011-300995","article-title":"A randomised, double-blind, sham-controlled study of granulocyte apheresis for moderate to severe Crohn's disease","volume":"62","author":"Sands","year":"2013","journal-title":"Gut"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/apt.13665","article-title":"Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a phase 3 study","volume":"44","author":"Schmidt","year":"2016","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0053|cit53","first-page":"48","article-title":"Surplus vitamin B12 use does not reduce fatigue in patients with irritable bowel syndrome or inflammatory bowel disease: a randomized double-blind placebo-controlled trial","volume":"23","author":"Scholten","year":"2018","journal-title":"Clinical Nutrition European Society for Clinical Nutrition and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD012005.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.gastro.2006.11.029","article-title":"A randomised, placebo-controlled, phase II study of tetomilast in active ulcerative colitis","volume":"132","author":"Schreiber","year":"2007","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD012005.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1007\/s10620-011-1653-7","article-title":"Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomised placebo-controlled trial","volume":"56","author":"Smith","year":"2011","journal-title":"Digestive Diseases and Sciences"},{"issue":"4","key":"10.1002\/14651858.CD012005.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MCG.0b013e3182702f2b","article-title":"Safety and tolerability of low dose naltrexone therapy in children with moderate to severe Crohn's disease: a pilot study","volume":"47","author":"Smith","year":"2013","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD012005.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/gast.2002.34225","article-title":"Combined budesonide and antibiotic therapy for active Crohn's disease: a randomised controlled trial","volume":"123","author":"Steinhart","year":"2002","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD012005.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/j.jaac.2016.09.340","article-title":"Brief behavioral therapy and bupropion for sleep and fatigue in adolescents and young adults with inflammatory bowel disease","volume":"55","author":"Szigethy","year":"2016","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD012005.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1053\/j.gastro.2007.03.024","article-title":"Natalizumab for the treatment of active Crohn's disease: results of the ENCORE trial","volume":"132","author":"Targan","year":"2007","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD012005.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1136\/gut.2008.165738","article-title":"Steriod-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study","volume":"58","author":"Valentine","year":"2009","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD012005.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/gutjnl-2011-300755","article-title":"Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial","volume":"61","author":"Assche","year":"2012","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD012005.pub2-BIB0062|cit62","first-page":"412","article-title":"Long-term efficacy of vedolizumab for Crohn\u2019s Disease","volume":"11","author":"Vermeire","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1093\/ecco-jcc\/jjy222.420","article-title":"Effect of upadacitinib on patient-reported symptoms by the new ulcerative colitis symptoms questionnaire (UC-SQ) in patients with moderate to severe ulcerative colitis: data from the Phase 2b study U-ACHIEVE","volume":"13","author":"Ghosh","year":"2019","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0064|cit64","unstructured":"NCT02819635 A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of upadacitinib (ABT-494) for induction and maintenance therapy in subjects with moderately to severely active ulcerative colitis clinicaltrials.gov\/ct2\/show\/NCT02819635"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1093\/ecco-jcc\/jjy222.497","article-title":"Effect of risankizumab on improved and sustained quality of life in patients with moderate to severe Crohn's disease: phase 2 trial results","volume":"13","author":"Louis","year":"2019","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0066|cit66","unstructured":"NCT02031276 A phase II, multicenter, randomized, double-blind, multiple dose, placebo-controlled, parallel-group study to evaluate the efficacy, pharmacokinetics, and safety of BI 655066\/ABBV-066 (risankizumab), and IL-23 p19 antagonist monoclonal antibody in patients with ,moderately to severely active Crohn's disease who are na\u00efve to, or were previously treated with, anti-TNF therapy clinicaltrials.gov\/ct2\/show\/NCT02031276"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0067|cit67","unstructured":"NCT02709434 The efficacy of a structured psychoeducational inflammatory bowel disease group on the control of fatigue in an adult outpatient setting for patients with objectively quiescent disease ClinicalTrials.gov\/show\/NCT02709434"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2040622319838439","article-title":"Randomized controlled trial: a pilot study of a psychoeducational intervention for fatigue in patients with quiescent inflammatory bowel disease","volume":"10","author":"O'Connor","year":"2019","journal-title":"Therapeutic Advances in Chronic Disease"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(18)32775-6","article-title":"Post hoc analysis of the impact of ustekinumab treatment on specific items of the Inflammatory Bowel Disease Questionnaire in the Uniti-1 & 2 programs","volume":"154","author":"Sands","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0070|cit70","unstructured":"ISRCTN13021107 A randomised controlled trial investigating the feasibility and acceptability of high-intensity interval training and moderate-intensity continuous training in adults with inactive or mildly active Crohn\u2019s disease www.isrctn.com\/ISRCTN13021107"},{"issue":"1","key":"10.1002\/14651858.CD012005.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12876-019-0936-x","article-title":"High-intensity interval training and moderate-intensity continuous training in adults with Crohn's disease: a pilot randomised controlled trial","volume":"19","author":"Tew","year":"2019","journal-title":"BMC Gastroenterology"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0072|cit72","unstructured":"ACTRN12617000586314P A prospective randomized multicentre study to evaluate the effect of intravenous iron infusion compared to oral iron supplementation on the quality of life in inflammatory bowel disease with non-anaemia hypoferritinanaemia https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=372758"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0073|cit73","unstructured":"ACTRN12619000150145 Influence of extra virgin olive oil intake on disease activity and gut microbiota profile of community dwelling adults with ulcerative colitis in comparison to healthy subjects https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=375208"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0074|cit74","unstructured":"EudraCT Number: 2008-004277-17 The effectiveness and tolerability of GlobiFer (haem iron) tablets compared to ferrous sulphate tablets in inflammatory bowel disease: a randomised-controlled trial https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2008-004277-17\/GB"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0075|cit75","unstructured":"EudraCT Number: 2011-002122-43 Iron therapy in IBD patients with normal levels of haemoglobin and chronic fatigue https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2011-002122-43"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0076|cit76","unstructured":"EUCTR2012-005644-26-BE Administration of intravenous ferric carboxymaltose to children with IBD https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=EUCTR2012-005644-26-BE"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0077|cit77","unstructured":"ISRCTN11470370 Effects of a 6-month practical resistance training programme on muscle function and bone mineral density in adults with inactive or mildly active Crohn\u2019s disease: Study protocol for a randomised controlled trial http:\/\/www.isrctn.com\/ISRCTN11470370"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0078|cit78","unstructured":"NCT02193750 Assessing the tolerability of oligosaccharide supplementation in patients with Crohn's disease: A randomized, controlled trial https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02193750"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0079|cit79","unstructured":"NCT02208310 A randomised controlled trial of high-dose vitamin D in Crohn's disease https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02208310"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0080|cit80","unstructured":"NCT02517151 Effects of iron therapy in patients with chronic fatigue and IBD https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02517151"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0081|cit81","unstructured":"NCT02704624 The impact of serum vitamin D and calcium levels on the body composition, bone mineral density, muscle strength, exercise tolerance, fatigue and inflammatory activity in patients with Crohn's disease: a randomized controlled trial https:\/\/ClinicalTrials.gov\/show\/NCT02704624"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0082|cit82","unstructured":"NCT02707068 Quality Of LIfe Tool for IBD (QOLITI): pilot testing of a self-administered intervention to target psychological distress in inflammatory bowel disease https:\/\/clinicaltrials.gov\/show\/NCT02707068"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0083|cit83","unstructured":"NCT02772965 A randomized, double-blind, placebo-controlled, multi-center pragmatic clinical trial to evaluate the effectiveness of low dose oral methotrexate in patients with pediatric Crohn's disease initiating anti-TNF therapy https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02772965"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0084|cit84","unstructured":"NCT02849717 Pre-habilitation exercise intervention for patients scheduled for colorectal surgical resection clinicaltrials.gov\/ct2\/show\/NCT02849717"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0085|cit85","unstructured":"NCT02861053 Inflammatory Bowel Disease: Could a regular physical activity reduce patients fatigue? https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02861053"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0086|cit86","unstructured":"NCT02891226 A phase 2, multicenter, randomized, parallel-arm, placebo-controlled study of LY3074828 in subjects with active Crohn's Disease (SERENITY) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02891226"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0087|cit87","unstructured":"NCT02963246 Effects of a mindfulness therapy intervention for individuals with inflammatory bowel disease: a randomized controlled trial https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02963246"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0088|cit88","unstructured":"NCT03104413 A multicenter, randomized, double-blind, placebo-controlled induction study to assess the efficacy and safety of Risankizumab in subjects with moderately to severely active Crohn's disease who failed prior biologic treatment https:\/\/clinicaltrials.gov\/show\/NCT03104413"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0089|cit89","unstructured":"NCT03105102 A multicenter, randomized, double-blind, placebo controlled 52-week maintenance and an open-label extension study of the efficacy and safety of Risankizumab in subjects with Crohn's disease who responded to induction treatment in M16-006 or M15-991; or completed M15-989 ClinicalTrials.gov\/show\/NCT03105102"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0090|cit90","unstructured":"NCT03105128 A multicenter, randomized, double-blind, placebo controlled induction study of the efficacy and safety of Risankizumab in subjects with moderately to severely active Crohn's disease ClinicalTrials.gov\/show\/NCT03105128"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0091|cit91","unstructured":"NCT03107793 Study of treat to target versus routine care maintenance strategies in Crohn's disease patients treated with Ustekinumab clinicaltrials.gov\/ct2\/show\/NCT03107793"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0092|cit92","unstructured":"NCT03162575 The possible beneficial effects of mindfulness-based cognitive therapy (MBCT) in fatigued adult patients with Inflammatory Bowel Disease (IBD) clinicaltrials.gov\/ct2\/show\/NCT03162575"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0093|cit93","unstructured":"NCT03266484 Effect of dietary therapy with a probiotic mixture on the gut microbiome and fatigue symptoms in patients with quiescent inflammatory bowel disease - A clinical trial clinicaltrials.gov\/ct2\/show\/NCT03266484"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0094|cit94","unstructured":"NCT03345823 A multicenter, randomized, double-blind, placebo-controlled maintenance and long-term extension study of the efficacy and safety of Upadacitinib (ABT-494) in subjects with Crohn's disease who completed the studies M14-431 or M14-433 clinicaltrials.gov\/ct2\/show\/NCT03345823"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0095|cit95","unstructured":"NCT03345836 A multicenter, randomized, double-blind, placebo-controlled induction study of the efficacy and safety of Upadacitinib (ABT-494) in subjects with moderately to severely active Crohn's disease who have inadequately responded to or are intolerant to biologic therapy clinicaltrials.gov\/ct2\/show\/NCT03345836"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0096|cit96","unstructured":"NCT03345849 A multicenter, randomized, double-blind, placebo-controlled induction study of the efficacy and safety of Upadacitinib (ABT-494) in subjects with moderately to severely active Crohn's disease who have inadequately responded to or are Intolerant to conventional and\/or biologic therapies clinicaltrials.gov\/ct2\/show\/NCT03345849"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0097|cit97","unstructured":"NCT03398135 A multicenter, randomized, double-blind, placebo controlled 52-week maintenance and an open-label extension study of the efficacy and safety of Risankizumab in subjects with ulcerative colitis who responded to induction treatment in M16-067 or M16-065 clinicaltrials.gov\/ct2\/show\/NCT03398135"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0098|cit98","unstructured":"NCT03398148 A multicenter, randomized, double-blind, placebo controlled induction study to evaluate the efficacy and safety of Risankizumab in subjects with moderately to severely active ulcerative colitis who have failed prior biologic therapy clinicaltrials.gov\/ct2\/show\/NCT03398148"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0099|cit99","unstructured":"NCT03456752 The Impact of perioperative dexamethasone on postoperative outcome in inflammatory bowel diseases clinicaltrials.gov\/ct2\/show\/NCT03456752"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0100|cit100","unstructured":"NCT03466411 A phase 2\/3, randomized, double-blind, placebo- and active-controlled, parallel-group, multicenter protocol to evaluate the efficacy and safety of Guselkumab in participants with moderately to severely active Crohn's disease clinicaltrials.gov\/ct2\/show\/NCT03466411"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0101|cit101","unstructured":"NCT03574948 Multicentric, double-blind, placebo controlled clinical trial with 5-hydroxytryptophan (5-HTP) in patients with inflammatory bowel disease in clinical and biologic remission: effect on fatigue scores clinicaltrials.gov\/ct2\/show\/NCT03574948"},{"issue":"6","key":"10.1002\/14651858.CD012005.pub2-BIB0102|cit102","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008334","article-title":"Biologic interventions for fatigue in rheumatoid arthritis","author":"Almeida","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012005.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2036.2011.04914.x","article-title":"Fatigue in out-patients with inflammatory bowel disease is common and multifactorial","volume":"35","author":"Bager","year":"2012","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD012005.pub2-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008144","article-title":"Educational interventions for the management of cancer-related fatigue in adults","author":"Bennett","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD012005.pub2-BIB0105|cit105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008144.pub2","article-title":"Educational interventions for the management of cancer-related fatigue in adults","author":"Bennett","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012005.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ibd.21048","article-title":"World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010","volume":"16","author":"Bernstein","year":"2010","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012005.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1023\/A:1005492806777","article-title":"Concerns of patients with inflammatory bowel disease: a review of emerging themes","volume":"45","author":"Casati","year":"2000","journal-title":"Digestive Diseases and Sciences"},{"issue":"5","key":"10.1002\/14651858.CD012005.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00042737-200105000-00017","article-title":"Influence of inflammatory bowel disease on different dimensions of quality of life","volume":"13","author":"Casellas","year":"2001","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD012005.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0885-3924(02)00529-8","article-title":"Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales","volume":"24","author":"Cella","year":"2002","journal-title":"Journal of Pain and Symptom Management"},{"issue":"5","key":"10.1002\/14651858.CD012005.pub2-BIB0110|cit110","first-page":"811","article-title":"Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis","volume":"32","author":"Cella","year":"2005","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD012005.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-3999(93)90081-P","article-title":"Development of a fatigue scale","volume":"37","author":"Chalder","year":"1993","journal-title":"Journal of Psychosomatic Research"},{"issue":"9","key":"10.1002\/14651858.CD012005.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1365-2036.2009.03966.x","article-title":"Evaluation of the meaningfulness of health-related quality of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn\u2019s disease","volume":"29","author":"Coteur","year":"2009","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD012005.pub2-BIB0113|cit113","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006145.pub3","article-title":"Exercise for the management of cancer-related fatigue in adults","author":"Cramp","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012005.pub2-BIB0114|cit114","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008322.pub2","article-title":"Non-pharmacological interventions for fatigue in rheumatoid arthritis","author":"Cramp","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/0-387-25808-6_13","article-title":"Understanding symptoms and signs in inflammatory bowel disease","volume-title":"Inflammatory Bowel Disease: From Bench to Bedside","author":"Cronin","year":"2005"},{"issue":"8","key":"10.1002\/14651858.CD012005.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.crohns.2014.01.004","article-title":"Healthcare professionals' perceptions of fatigue experienced by people with IBD","volume":"8","author":"Czuber-Dochan","year":"2014","journal-title":"Journal of Crohn's and Colitis"},{"issue":"8","key":"10.1002\/14651858.CD012005.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12968\/gasn.2014.12.8.13","article-title":"Assessing fatigue in patients with inflammatory bowel disease","volume":"12","author":"Czuber-Dochan","year":"2014","journal-title":"Gastrointestinal Nursing"},{"issue":"11","key":"10.1002\/14651858.CD012005.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.crohns.2014.04.013","article-title":"Development and psychometric testing of inflammatory bowel disease fatigue (IBD-F) patient self-assessment scale","volume":"8","author":"Czuber-Dochan","year":"2014","journal-title":"Journal of Crohn's and Colitis"},{"issue":"5","key":"10.1002\/14651858.CD012005.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/apt.12205","article-title":"Review article: description and management of fatigue in inflammatory bowel disease","volume":"37","author":"Czuber-Dochan","year":"2013","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD012005.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1111\/jan.12060","article-title":"The experience of fatigue in people with inflammatory bowel disease: an exploratory study","volume":"69","author":"Czuber-Dochan","year":"2013","journal-title":"Journal of Advanced Nursing"},{"issue":"4","key":"10.1002\/14651858.CD012005.pub2-BIB0121|cit121","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011376.pub2","article-title":"Interventions for the management of fatigue in adults with a primary brain tumour","author":"Day","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012005.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1572-0241.2001.03877.x","article-title":"Concerns of patients with inflammatory bowel disease: results from a clinical population","volume":"96","author":"Rooy","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0123|cit123","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane\u2013handbook.org."},{"issue":"2","key":"10.1002\/14651858.CD012005.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-3999(03)00371-4","article-title":"The assessment of fatigue: a practical guide for clinicians and researchers","volume":"56","author":"Dittner","year":"2004","journal-title":"Journal of Psychosomatic Research"},{"issue":"9","key":"10.1002\/14651858.CD012005.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/BF01538073","article-title":"Health-related quality of life in inflammatory bowel disease","volume":"34","author":"Drossman","year":"1989","journal-title":"Digestive Diseases and Sciences"},{"issue":"10","key":"10.1002\/14651858.CD012005.pub2-BIB0126|cit126","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010925.pub2","article-title":"Interventions for fatigue in Parkinson's disease","author":"Elbers","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0127|cit127","volume-title":"Symptom Burden in Individuals with Inflammatory Bowel Disease: a Mixed Methods Study [PhD thesis]","author":"Farrell","year":"2013"},{"issue":"3","key":"10.1002\/14651858.CD012005.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ecco-jcc\/jjv218","article-title":"Self-reported symptom burden in individuals with inflammatory bowel disease","volume":"10","author":"Farrell","year":"2016","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD012005.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/clinids\/18.Supplement_1.S79","article-title":"Measuring the functional impact of fatigue: initial validation of the fatigue impact scale","volume":"18","author":"Fisk","year":"1994","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012005.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/A:1015295106602","article-title":"Construction and validation of a fatigue impact scale for daily administration (D-FIS)","volume":"11","author":"Fisk","year":"2002","journal-title":"Quality of Life Research"},{"issue":"4","key":"10.1002\/14651858.CD012005.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0005-7967(03)00146-3","article-title":"A stress management programme for Crohn\u2019s disease","volume":"42","author":"Garcia-Vega","year":"2004","journal-title":"Behaviour Research and Therapy"},{"issue":"1","key":"10.1002\/14651858.CD012005.pub2-BIB0132|cit132","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011005.pub2","article-title":"Treatment of fatigue in amyotrophic lateral sclerosis\/motor neuron disease","author":"Gibbons","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012005.pub2-BIB0133|cit133","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006953.pub2","article-title":"Psychosocial interventions for reducing fatigue during cancer treatment in adults","author":"Goedendorp","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012005.pub2-BIB0134|cit134","first-page":"635","article-title":"Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus","volume":"35","author":"Goligher","year":"2008","journal-title":"Journal of Rheumatology"},{"issue":"9","key":"10.1002\/14651858.CD012005.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/ibd.21580","article-title":"A population-based study of fatigue and sleep difficulties in inflammatory bowel disease","volume":"17","author":"Graff","year":"2011","journal-title":"Inflammatory Bowel Diseases"},{"issue":"9","key":"10.1002\/14651858.CD012005.pub2-BIB0136|cit136","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009956.pub2","article-title":"Exercise therapy for fatigue in multiple sclerosis","author":"Heine","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0137|cit137","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0138|cit138","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD012005.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7525-5-12","article-title":"Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales","volume":"5","author":"Hjollund","year":"2007","journal-title":"Health Quality Life Outcomes"},{"issue":"4","key":"10.1002\/14651858.CD012005.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/00005176-199904001-00003","article-title":"Development and subsequent refinement of the inflammatory bowel disease questionnaire: a quality-of-life instrument for adult patients with inflammatory bowel disease","volume":"28","author":"Irvine","year":"1999","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0141|cit141","doi-asserted-by":"publisher","first-page":"492034","DOI":"10.1155\/2011\/492034","article-title":"Worries and concerns among inflammatory bowel disease patients followed prospectively over one year","volume":"2011","author":"Jelsness-J\u00f8rgensen","year":"2011","journal-title":"Gastroenterology Research and Practice"},{"issue":"5","key":"10.1002\/14651858.CD012005.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3748\/wjg.v18.i5.445","article-title":"Chronic fatigue is associated with increased disease-related worries and concerns in inflammatory bowel disease","volume":"18","author":"Jelsness-J\u00f8rgensen","year":"2012","journal-title":"World Journal of Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD012005.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/ibd.21530","article-title":"Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls","volume":"17","author":"Jelsness-J\u00f8rgensen","year":"2011","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012005.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2036.2010.04498.x","article-title":"Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease","volume":"33","author":"Jelsness-J\u00f8rgensen","year":"2011","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD012005.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD012005.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1023\/A:1025014509626","article-title":"Item banking to improve, shorten and computerize self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-Fatigue Scale","volume":"12","author":"Lai","year":"2003","journal-title":"Quality of Life Research"},{"issue":"4","key":"10.1002\/14651858.CD012005.pub2-BIB0147|cit147","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003200.pub7","article-title":"Exercise therapy for chronic fatigue syndrome","author":"Larun","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012005.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0165-1781(91)90027-M","article-title":"Validity and reliability of a scale to assess fatigue","volume":"36","author":"Lee","year":"1991","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0149|cit149","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"5","key":"10.1002\/14651858.CD012005.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1572-0241.2003.07414.x","article-title":"High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency","volume":"98","author":"Minderhoud","year":"2003","journal-title":"American Journal of Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD012005.pub2-BIB0151|cit151","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006704.pub3","article-title":"Drug therapy for the management of cancer-related fatigue","author":"Minton","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012005.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD012005.pub2-BIB0153|cit153","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006788.pub3","article-title":"Pharmacological treatments for fatigue associated with palliative care","author":"M\u00fccke","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012005.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s11136-013-0508-4","article-title":"Fatigue interference with daily living among patients with inflammatory bowel disease","volume":"23","author":"Opheim","year":"2014","journal-title":"Quality of Life Research"},{"issue":"4","key":"10.1002\/14651858.CD012005.pub2-BIB0155|cit155","first-page":"677","article-title":"The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer","volume":"25","author":"Piper","year":"1998","journal-title":"Oncology Nursing Forum"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jclinepi.2007.08.016","article-title":"Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis","volume":"61","author":"Pouchot","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012005.pub2-BIB0157|cit157","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009007.pub2","article-title":"Blood transfusions for anaemia in patients with advanced cancer","author":"Preston","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012005.pub2-BIB0158|cit158","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001027.pub2","article-title":"Cognitive behaviour therapy for chronic fatigue syndrome in adults","author":"Price","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012005.pub2-BIB0159|cit159","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002818.pub2","article-title":"Amantadine for fatigue in multiple sclerosis","author":"Pucci","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0160|cit160","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0161|cit161","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD012005.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/bjc.1996.42","article-title":"Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy","volume":"73","author":"Smets","year":"1996","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0163|cit163","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"8","key":"10.1002\/14651858.CD012005.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ejca.2008.02.037","article-title":"Cancer-related fatigue","volume":"44","author":"Stone","year":"2008","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0165|cit165","volume-title":"Dimensions and Correlates of Fatigue in Older Adults with Rheumatoid Arthritis [PhD thesis]","author":"Tack","year":"1991"},{"issue":"5","key":"10.1002\/14651858.CD012005.pub2-BIB0166|cit166","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007280.pub3","article-title":"Carnitine for fatigue in multiple sclerosis","author":"Tejani","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012005.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2036.2010.04347.x","article-title":"Systematic review: fatigue in inflammatory bowel disease","volume":"32","author":"Langenberg","year":"2010","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD012005.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"issue":"12","key":"10.1002\/14651858.CD012005.pub2-BIB0169|cit169","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008146.pub2","article-title":"Interventions for fatigue in peripheral neuropathy","author":"White","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012005.pub2-BIB0170|cit170","unstructured":"Wilson B L\u00f6nnfors S Vermeire S The true impact of IBD: a European Crohn's and Ulcerative Colitis patient life. IMPACT Survey 2010-2011 21st Century Challenges Autoimmune Diseases. European Federation of Crohn\u2019s and Ulcerative Colitis Associations (EFCCA), Brussels, Belgium; European Crohn\u2019s and Colitis Organization (ECCO); 2012; Vienna, Austria 2012"},{"issue":"2","key":"10.1002\/14651858.CD012005.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","article-title":"Measuring fatigue and other anaemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system","volume":"13","author":"Yellen","year":"1997","journal-title":"Journal of Pain and Symptom Management"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T22:03:06Z","timestamp":1704232986000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012005.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":171,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012005.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]}}}